- Home
- Publications
- Publications Database
-
Arbaclofen in children and adolescents with autism spectrum disorder: A randomized, controlled, phase 2 trial.
This page provides detailed information about this publication. Please click on any text which is underlined to find more information.
- Authors
- Jeremy Veenstra-VanderWeele, Edwin H. Cook, Bryan H. King, Peter Zarevics, Maryann Cherubini, Karen Walton-Bowen, Mark F. Bear, Paul P. Wang, Randall L. Carpenter
- Title
- Arbaclofen in children and adolescents with autism spectrum disorder: A randomized, controlled, phase 2 trial.
- Journal
- Neuropsychopharmacology
- Abstract Link
- Read Abstract (New Window)
- Publication Format
- Journal Article
- Efficacy Study/Review
- Yes
- Scientific Validity
- Peer-Reviewed, Randomised Trial, Controlled Trial, Double Blind, Placebo, Multisite
- Keywords
- Adolescent / Secondary School Age, Adult, Arbaclofen, Asperger Syndrome, Autism, Autistic Disorder, Child/Children, GABA Receptor Agonist, Gamma Aminobutyric Acid, Intervention, Medication, Pervasive Developmental Disorder (Not Otherwise Specified), Social Skills
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.